Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Handing Off the Older Patient: Improved Documentation of Geriatric Assessment in Transitions of Care.

Blomberg BA, Mulligan RC, Staub SJ, Hanson LC, Drickamer MA, Dale MC.

J Am Geriatr Soc. 2018 Feb;66(2):401-406. doi: 10.1111/jgs.15237. Epub 2017 Dec 18.

PMID:
29251766
2.

Familial influences on the full range of variability in attention and activity levels during adolescence: A longitudinal twin study.

Peng CZ, Grant JD, Heath AC, Reiersen AM, Mulligan RC, Anokhin AP.

Dev Psychopathol. 2016 May;28(2):517-26. doi: 10.1017/S0954579415001091. Epub 2015 Nov 27.

3.

The genetics of impulsivity: evidence for the heritability of delay discounting.

Anokhin AP, Grant JD, Mulligan RC, Heath AC.

Biol Psychiatry. 2015 May 15;77(10):887-94. doi: 10.1016/j.biopsych.2014.10.022. Epub 2014 Nov 7.

4.

Development of gene transfer technology.

Mulligan RC.

Hum Gene Ther. 2014 Dec;25(12):995-1002. doi: 10.1089/hum.2014.2543. Review. No abstract available.

PMID:
25513845
5.

Long-term test-retest reliability of delayed reward discounting in adolescents.

Anokhin AP, Golosheykin S, Mulligan RC.

Behav Processes. 2015 Feb;111:55-9. doi: 10.1016/j.beproc.2014.11.008. Epub 2014 Nov 15.

6.

Neural correlates of inhibitory control and functional genetic variation in the dopamine D4 receptor gene.

Mulligan RC, Kristjansson SD, Reiersen AM, Parra AS, Anokhin AP.

Neuropsychologia. 2014 Sep;62:306-18. doi: 10.1016/j.neuropsychologia.2014.07.033. Epub 2014 Aug 5.

7.

Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype.

Xu X, Clark US, David SP, Mulligan RC, Knopik VS, McGeary J, MacKillop J, McCaffery J, Niaura RS, Sweet LH.

Nicotine Tob Res. 2014 Jul;16(7):939-47. doi: 10.1093/ntr/ntu010. Epub 2014 Mar 22.

8.

Attention-Deficit/Hyperactivity Disorder, Autistic Traits, and Substance Use Among Missouri Adolescents.

Mulligan RC, Reiersen AM, Todorov AA.

Scand J Child Adolesc Psychiatr Psychol. 2014;2(2):86-92.

9.

Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells.

Burkhardt UE, Hainz U, Stevenson K, Goldstein NR, Pasek M, Naito M, Wu D, Ho VT, Alonso A, Hammond NN, Wong J, Sievers QL, Brusic A, McDonough SM, Zeng W, Perrin A, Brown JR, Canning CM, Koreth J, Cutler C, Armand P, Neuberg D, Lee JS, Antin JH, Mulligan RC, Sasada T, Ritz J, Soiffer RJ, Dranoff G, Alyea EP, Wu CJ.

J Clin Invest. 2013 Sep;123(9):3756-65. doi: 10.1172/JCI69098. Epub 2013 Aug 5.

10.

Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patients.

Brusic A, Hainz U, Wadleigh M, Neuberg D, Su M, Canning CM, Deangelo DJ, Stone RM, Lee JS, Mulligan RC, Ritz J, Dranoff G, Sasada T, Wu CJ.

Oncoimmunology. 2012 Oct 1;1(7):1095-1103.

11.

Effects of HIV and early life stress on amygdala morphometry and neurocognitive function.

Clark US, Cohen RA, Sweet LH, Gongvatana A, Devlin KN, Hana GN, Westbrook ML, Mulligan RC, Jerskey BA, White TL, Navia B, Tashima KT.

J Int Neuropsychol Soc. 2012 Jul;18(4):657-68. doi: 10.1017/S1355617712000434. Epub 2012 May 24.

12.

A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.

Herson S, Hentati F, Rigolet A, Behin A, Romero NB, Leturcq F, Laforêt P, Maisonobe T, Amouri R, Haddad H, Audit M, Montus M, Masurier C, Gjata B, Georger C, Cheraï M, Carlier P, Hogrel JY, Herson A, Allenbach Y, Lemoine FM, Klatzmann D, Sweeney HL, Mulligan RC, Eymard B, Caizergues D, Voït T, Benveniste O.

Brain. 2012 Feb;135(Pt 2):483-92. doi: 10.1093/brain/awr342. Epub 2012 Jan 11.

PMID:
22240777
13.

Neural correlates of inhibitory control in adult attention deficit/hyperactivity disorder: evidence from the Milwaukee longitudinal sample.

Mulligan RC, Knopik VS, Sweet LH, Fischer M, Seidenberg M, Rao SM.

Psychiatry Res. 2011 Nov 30;194(2):119-29. doi: 10.1016/j.pscychresns.2011.02.003. Epub 2011 Sep 21.

14.

Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy.

Schwenter F, Zarei S, Luy P, Padrun V, Bouche N, Lee JS, Mulligan RC, Morel P, Mach N.

Cancer Gene Ther. 2011 Aug;18(8):553-62. doi: 10.1038/cgt.2011.22. Epub 2011 May 13.

PMID:
21566667
15.

Recombinant adeno-associated virus type 2 pseudotypes: comparing safety, specificity, and transduction efficiency in the primate striatum. Laboratory investigation.

Sanchez CE, Tierney TS, Gale JT, Alavian KN, Sahin A, Lee JS, Mulligan RC, Carter BS.

J Neurosurg. 2011 Mar;114(3):672-80. doi: 10.3171/2010.8.JNS091583. Epub 2010 Oct 15.

16.

Effects of nicotine withdrawal on verbal working memory and associated brain response.

Sweet LH, Mulligan RC, Finnerty CE, Jerskey BA, David SP, Cohen RA, Niaura RS.

Psychiatry Res. 2010 Jul 30;183(1):69-74. doi: 10.1016/j.pscychresns.2010.04.014. Epub 2010 Jun 8.

17.

Amelioration of emphysema in mice through lentiviral transduction of long-lived pulmonary alveolar macrophages.

Wilson AA, Murphy GJ, Hamakawa H, Kwok LW, Srinivasan S, Hovav AH, Mulligan RC, Amar S, Suki B, Kotton DN.

J Clin Invest. 2010 Jan;120(1):379-89. doi: 10.1172/JCI36666. Epub 2009 Dec 21.

18.

A fMRI Study of Verbal Working Memory, Cardiac Output, and Ejection Fraction in Elderly Patients with Cardiovascular Disease.

Irani F, Sweet LH, Haley AP, Gunstad JJ, Jerskey BA, Mulligan RC, Jefferson AL, Poppas A, Cohen RA.

Brain Imaging Behav. 2009 Dec;3(4):350-357.

19.

Genetically engineered T cells to target EGFRvIII expressing glioblastoma.

Bullain SS, Sahin A, Szentirmai O, Sanchez C, Lin N, Baratta E, Waterman P, Weissleder R, Mulligan RC, Carter BS.

J Neurooncol. 2009 Sep;94(3):373-82. doi: 10.1007/s11060-009-9889-1. Epub 2009 Apr 23.

20.

A mammalian cell-based assay for screening inhibitors of RNA cleavage.

Yen L, Stockwell BR, Mulligan RC.

Methods Mol Biol. 2009;540:335-47. doi: 10.1007/978-1-59745-558-9_24.

PMID:
19381571
21.

Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis.

Kuhnert F, Tam BY, Sennino B, Gray JT, Yuan J, Jocson A, Nayak NR, Mulligan RC, McDonald DM, Kuo CJ.

Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10185-90. doi: 10.1073/pnas.0803194105. Epub 2008 Jul 16.

22.

Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D.

Rodino-Klapac LR, Lee JS, Mulligan RC, Clark KR, Mendell JR.

Neurology. 2008 Jul 22;71(4):240-7. doi: 10.1212/01.wnl.0000306309.85301.e2. Epub 2008 Jun 4.

PMID:
18525034
23.

Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation.

Szentirmai O, Baker CH, Bullain SS, Lin N, Takahashi M, Folkman J, Mulligan RC, Carter BS.

J Neurosurg. 2008 May;108(5):979-88. doi: 10.3171/JNS/2008/108/5/0979.

24.

Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome.

Austin KM, Gupta ML Jr, Coats SA, Tulpule A, Mostoslavsky G, Balazs AB, Mulligan RC, Daley G, Pellman D, Shimamura A.

J Clin Invest. 2008 Apr;118(4):1511-8. doi: 10.1172/JCI33764.

25.

Imaging phonological similarity effects on verbal working memory.

Sweet LH, Paskavitz JF, Haley AP, Gunstad JJ, Mulligan RC, Nyalakanti PK, Cohen RA.

Neuropsychologia. 2008 Mar 7;46(4):1114-23. Epub 2007 Nov 9.

PMID:
18155074
26.

Engineering high-speed allosteric hammerhead ribozymes.

Link KH, Guo L, Ames TD, Yen L, Mulligan RC, Breaker RR.

Biol Chem. 2007 Aug;388(8):779-86.

PMID:
17655496
27.

Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell.

Butler MO, Lee JS, Ansén S, Neuberg D, Hodi FS, Murray AP, Drury L, Berezovskaya A, Mulligan RC, Nadler LM, Hirano N.

Clin Cancer Res. 2007 Mar 15;13(6):1857-67.

28.

Consequences of Shb and c-Abl interactions for cell death in response to various stress stimuli.

Hägerkvist R, Mokhtari D, Lindholm C, Farnebo F, Mostoslavsky G, Mulligan RC, Welsh N, Welsh M.

Exp Cell Res. 2007 Jan 15;313(2):284-91. Epub 2006 Oct 24.

PMID:
17112510
29.

Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer.

Mostoslavsky G, Fabian AJ, Rooney S, Alt FW, Mulligan RC.

Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16406-11. Epub 2006 Oct 24.

30.

Exogenous control of mammalian gene expression via modulation of translational termination.

Murphy GJ, Mostoslavsky G, Kotton DN, Mulligan RC.

Nat Med. 2006 Sep;12(9):1093-9. Epub 2006 Aug 6.

PMID:
16892063
31.

VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis.

Tam BY, Wei K, Rudge JS, Hoffman J, Holash J, Park SK, Yuan J, Hefner C, Chartier C, Lee JS, Jiang S, Nayak NR, Kuypers FA, Ma L, Sundram U, Wu G, Garcia JA, Schrier SL, Maher JJ, Johnson RS, Yancopoulos GD, Mulligan RC, Kuo CJ.

Nat Med. 2006 Jul;12(7):793-800. Epub 2006 Jun 25. Erratum in: Nat Med. 2009 Apr;15(4):462. Niyak, Nihar R [corrected to Nayak, Nihar R].

PMID:
16799557
32.

Identification of inhibitors of ribozyme self-cleavage in mammalian cells via high-throughput screening of chemical libraries.

Yen L, Magnier M, Weissleder R, Stockwell BR, Mulligan RC.

RNA. 2006 May;12(5):797-806. Epub 2006 Mar 23.

33.
34.

Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow.

Balazs AB, Fabian AJ, Esmon CT, Mulligan RC.

Blood. 2006 Mar 15;107(6):2317-21. Epub 2005 Nov 22.

35.

Engineering vascularized skeletal muscle tissue.

Levenberg S, Rouwkema J, Macdonald M, Garfein ES, Kohane DS, Darland DC, Marini R, van Blitterswijk CA, Mulligan RC, D'Amore PA, Langer R.

Nat Biotechnol. 2005 Jul;23(7):879-84. Epub 2005 Jun 19.

PMID:
15965465
36.

Failure of bone marrow to reconstitute lung epithelium.

Kotton DN, Fabian AJ, Mulligan RC.

Am J Respir Cell Mol Biol. 2005 Oct;33(4):328-34. Epub 2005 Jun 16.

37.
38.

A novel stem-cell population in adult liver with potent hematopoietic-reconstitution activity.

Kotton DN, Fabian AJ, Mulligan RC.

Blood. 2005 Sep 1;106(5):1574-80. Epub 2005 May 3.

39.

Exogenous control of mammalian gene expression through modulation of RNA self-cleavage.

Yen L, Svendsen J, Lee JS, Gray JT, Magnier M, Baba T, D'Amato RJ, Mulligan RC.

Nature. 2004 Sep 23;431(7007):471-6.

PMID:
15386015
40.

Transplantation of islets transduced with CTLA4-Ig and TGFbeta using adenovirus and lentivirus vectors.

Fernandes JR, Duvivier-Kali VF, Keegan M, Hollister-Lock J, Omer A, Su S, Bonner-Weir S, Feng S, Lee JS, Mulligan RC, Weir GC.

Transpl Immunol. 2004 Nov;13(3):191-200.

PMID:
15381202
41.

Nitric oxide is a regulator of hematopoietic stem cell activity.

Michurina T, Krasnov P, Balazs A, Nakaya N, Vasilieva T, Kuzin B, Khrushchov N, Mulligan RC, Enikolopov G.

Mol Ther. 2004 Aug;10(2):241-8.

42.

Dose-dependent response of FGF-2 for lymphangiogenesis.

Chang LK, Garcia-Cardeña G, Farnebo F, Fannon M, Chen EJ, Butterfield C, Moses MA, Mulligan RC, Folkman J, Kaipainen A.

Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11658-63. Epub 2004 Aug 2.

43.

TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.

Perron MJ, Stremlau M, Song B, Ulm W, Mulligan RC, Sodroski J.

Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11827-32. Epub 2004 Jul 27.

44.

Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cells.

Podar K, Mostoslavsky G, Sattler M, Tai YT, Hayashi T, Catley LP, Hideshima T, Mulligan RC, Chauhan D, Anderson KC.

J Biol Chem. 2004 May 14;279(20):21658-65. Epub 2004 Mar 9.

45.

Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells.

Matsuzaki Y, Kinjo K, Mulligan RC, Okano H.

Immunity. 2004 Jan;20(1):87-93.

46.

Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy.

Griese DP, Ehsan A, Melo LG, Kong D, Zhang L, Mann MJ, Pratt RE, Mulligan RC, Dzau VJ.

Circulation. 2003 Nov 25;108(21):2710-5. Epub 2003 Nov 3.

PMID:
14597586
47.

Gene therapy to target dendritic cells from blood to lymph nodes.

Robert C, Klein C, Cheng G, Kogan A, Mulligan RC, von Andrian UH, Kupper TS.

Gene Ther. 2003 Aug;10(17):1479-86.

PMID:
12900763
48.

Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor Flk1.

Becker CM, Farnebo FA, Iordanescu I, Behonick DJ, Shih MC, Dunning P, Christofferson R, Mulligan RC, Taylor GA, Kuo CJ, Zetter BR.

Cancer Biol Ther. 2002 Sep-Oct;1(5):548-53.

PMID:
12496487
49.

Gene therapy for pancreatic cancer.

Tseng JF, Mulligan RC.

Surg Oncol Clin N Am. 2002 Jul;11(3):537-69. Review.

PMID:
12487056
50.

Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice.

Tseng JF, Farnebo FA, Kisker O, Becker CM, Kuo CJ, Folkman J, Mulligan RC.

Surgery. 2002 Nov;132(5):857-65.

PMID:
12464871

Supplemental Content

Loading ...
Support Center